GlaxoSmithKline Q3 net declines 33.73% to Rs 100.95 cr

Comments 0
GlaxoSmithKline Pharmaceuticals' total income declined by 7.02 per cent to Rs 666.02 crore in the July-September quarter. GlaxoSmithKline Pharmaceuticals' total income declined by 7.02 per cent to Rs 666.02 crore in the July-September quarter.
SummaryCompany's total income declined by 7.02 per cent to Rs 666.02 crore in the July-September quarter.

Drug firm GlaxoSmithKline Pharmaceuticals (GSK) today reported 33.73 per cent decline in standalone net profit at Rs 100.95 crore for the third quarter ended September 30, 2013.

The company had posted a standalone net profit of Rs 152.34 crore in the same period previous fiscal, GSK Pharma said in a filing with the BSE.

The company follows January to December financial year.

The company's total income declined by 7.02 per cent to Rs 666.02 crore in the July-September quarter, compared to Rs 716.37 crore during the same period last year.

GlaxoSmithKline Pharmaceuticals shares were trading at Rs 2,448 per scrip at BSE in the afternoon trade, down 1.33 per cent from their previous close.

Ads by Google
Reader´s Comments
| Post a Comment
Please Wait while comments are loading...